Option Care Health (OPCH) Stock Price, News & Analysis

Company Overview

Option Care Health, Inc. (NASDAQ: OPCH) is a provider of home and alternate-site infusion services in the United States. The company works with patients, physicians, hospitals, health plans and pharmaceutical manufacturers to deliver and manage infusion therapy outside traditional hospital settings, including in patients’ homes, ambulatory infusion suites and other community-based locations.

Its services include the provision and administration of specialty medications and other infusion therapies for conditions such as infections, immune disorders, chronic diseases and nutritional deficiencies. Option Care Health also provides nursing support, clinical monitoring, patient education, care coordination and pharmacy services designed to support treatment adherence and help patients transition from hospital care to home-based therapy.

The company was formed through the combination of Option Care and BioScrip, which completed in 2019, and adopted the Option Care Health name in 2020. It serves patients across the United States through a nationwide network of pharmacies, infusion centers and clinical professionals. John C. Rademacher serves as the company’s president and chief executive officer.

Key Stats

• Today's Range: $31.03 to $31.11
• 50-Day Range: $22.49 to $31.07
• 52-Week Range: $18.01 to $36.80
• Volume: 6.21 million shs
• Average Volume: 6.66 million shs
• Market Capitalization: $4.65 billion
• P/E Ratio: 23.36
• Dividend Yield: N/A
• Price Target: $29.17
• Consensus Rating: Hold

Option Care Health Stock Analysis - MarketRank™

Option Care Health scored higher than 61% of companies evaluated by MarketBeat, and ranked 343rd out of 883 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 2.1 / 5
• Analyst Rating: Hold

Consensus Rating

Option Care Health has received a consensus rating of Hold. The company's average rating score is 2.13, and is based on no strong buy ratings, 2 buy ratings, 14 hold ratings, and no sell ratings.

Downside Risk

Option Care Health has a consensus price target of $29.17, representing about 6.1% downside from its current price of $31.07.

Amount of Analyst Coverage

Option Care Health has been the subject of 10 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

Earnings and Valuation

• Score: 2.5 / 5
• Proj. Earnings Growth: 11.18%

Earnings Growth

Earnings for Option Care Health are expected to grow by 11.18% in the coming year, from $1.70 to $1.89 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Option Care Health is 23.36, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 39.05.

Price to Earnings Ratio vs. Sector

The P/E ratio of Option Care Health is 23.36, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 275.02.

Price to Earnings Growth Ratio

Option Care Health has a PEG Ratio of 1.89. PEG Ratios above 1 indicate that a company could be overvalued.

Price to Book Value per Share Ratio

Option Care Health has a P/B Ratio of 3.72. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

Short Interest

• Score: 4.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

5.81% of the float of Option Care Health has been sold short.

Short Interest Ratio / Days to Cover

Option Care Health has a short interest ratio ("days to cover") of 3.47, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Option Care Health has recently decreased by 29.24%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Option Care Health does not currently pay a dividend.

Dividend Growth

Option Care Health does not have a long track record of dividend growth.

News and Social Media

• Score: 3.6 / 5
• News Sentiment: 0.84

News Sentiment

Option Care Health has a news sentiment score of 0.84. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.65 average news sentiment score of Healthcare companies.

News Coverage This Week

MarketBeat has tracked 40 news articles for Option Care Health this week, compared to 4 articles on an average week.

Search Interest

7 people have searched for OPCH on MarketBeat in the last 30 days. This is an increase of 250% compared to the previous 30 days.

MarketBeat Follows

Only 1 people have added Option Care Health to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days.

Company Ownership

• Score: 0.8 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Option Care Health insiders have not sold or bought any company stock.

Percentage Held by Insiders

1.70% of the stock of Option Care Health is held by insiders.

Percentage Held by Institutions

98.05% of the stock of Option Care Health is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

Company Calendar

• Last Earnings: 7/29/2026
• Today: 10/10/2026
• Next Earnings (Estimated): 11/04/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Healthcare
• Industry: Healthcare Providers & Services
• Sub-Industry: Healthcare Services
• Current Symbol: NASDAQ:OPCH
• CIK: 1014739
• Web: www.optioncarehealth.com
• Phone: (312) 940-2443
• Fax: 952-979-3969
• Employees: 8,266
• Year Founded: 1979

Price Target and Rating

• Average Price Target for Option Care Health: $29.17
• High Price Target: $38.00
• Low Price Target: $22.00
• Potential Upside/Downside: -6.1%
• Consensus Rating: Hold
• Rating Score (0-4): 2.13
• Research Coverage: 16 Analysts

Profitability

• EPS (Trailing Twelve Months): $1.33
• Trailing P/E Ratio: 23.36
• Forward P/E Ratio: 18.28
• P/E Growth: 1.89
• Net Income: $207.59 million
• Net Margins: 3.68%
• Pretax Margin: 5.01%
• Return on Equity: 18.74%
• Return on Assets: 7.25%

Debt

• Debt-to-Equity Ratio: 0.91
• Current Ratio: 1.47
• Quick Ratio: 0.98

Sales & Book Value

• Annual Sales: $5.65 billion
• Price / Sales: 0.82
• Cash Flow: $2.04 per share
• Price / Cash Flow: 15.20
• Book Value: $8.36 per share
• Price / Book: 3.72

Miscellaneous

• Outstanding Shares: 149,790,000
• Free Float: 147,239,000
• Market Cap: $4.65 billion
• Optionable: Optionable
• Beta: 0.58